收藏切换
Effect analysis of high-dose dexamethasone combined with rafutrombopag in the treatment of primary immunologic thrombocytopenic purpura
收藏切换
Huiying ZHAO, Shengyu MA, Yun YANG, Xuexue LI
World Clinical Drug | 2025, 46(2) : 164 - 169
Less
收藏切换
World Clinical Drug | 2025, 46(2): 164-169
• Article •
Effect analysis of high-dose dexamethasone combined with rafutrombopag in the treatment of primary immunologic thrombocytopenic purpura
Full
Huiying ZHAO, Shengyu MA, Yun YANG, Xuexue LI
Affiliations
  • Department of Hematology, Suzhou Municipal Hospital of Anhui Province, Suzhou 234000, Anhui Province, China
Published: 2025-02-10 doi: 10.13683/j.wph.2025.02.008
Outline
收藏切换
Objective

To observe the efficacy of high-dose dexamethasone(DXM) combined with rafutrombopag in the treatment of newly diagnosed primary immunologic thrombocytopenic purpura(ITP).

Methods

A total of 80 newly diagnosed primary ITP patients in our hospital from June 2020 to June 2023 were enrolled and divided into control group(high-dose DXM) and study group(high-dose DXM+rafutrombopag) by district randomization method, with 40 cases in each group. Platelet count(PLT) levels, the distribution of T lymphocyte subsets, efficacy and the occurrence of adverse reactions were compared between the two groups before treatment and at D7, D14, D30 and D60 of treatment.

Results

At D7, D14, D30 and D60 of treatment, the PLT levels in both groups were higher than before(P<0.05), and the PLT levels of the study group were higher than those in the control group at D7, D14 and D30(P<0.05). After treatment, cluster of differentiation(CD)3+, CD4+, CD4+/CD8+, complement C3, complement C4 and interleukin(IL)-4 in both groups were increased compared with those before treatment(P<0.05), and the study group was higher than the control group(P<0.05). The levels of CD8+, IL-2, IL-10 and interferon in both groups were lower than before treatment(P<0.05), and the study group was lower than the control group(P<0.05). The total effective rate of the study group was higher than that of the control group(85.00% vs. 65.00%, P<0.05), the rate of DXM secondary administration(10.00% vs. 30.00%, P<0.05) and the incidence of adverse reactions(25.00% vs. 52.50%, P<0.05) were lower than those of the control group.

Conclusion

High-dose DXM combined with rafutrombopag in the treatment of newly diagnosed primary ITP can effectively up-regulate PLT level, improve the distribution of T lymphocyte subsets, improve efficacy, and reduce the rate of DXM secondary administration and the incidence of adverse reactions.

high-dose dexamethasone  /  rafutrombopag  /  primary immunologic thrombocytopenic purpura
赵会英, 马圣宇, 杨云, 李雪雪. 大剂量地塞米松联合海曲泊帕治疗原发性免疫性血小板减少症效果分析. 世界临床药物, 2025 , 46 (2) : 164 -169 . DOI: 10.13683/j.wph.2025.02.008
Huiying ZHAO, Shengyu MA, Yun YANG, Xuexue LI. Effect analysis of high-dose dexamethasone combined with rafutrombopag in the treatment of primary immunologic thrombocytopenic purpura[J]. World Clinical Drug, 2025 , 46 (2) : 164 -169 . DOI: 10.13683/j.wph.2025.02.008
Year 2025 volume 46 Issue 2
46
12
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.02.008
  • Receive Date:2024-06-28
  • Online Date:2026-11-09
  • Published:2025-02-10
Article Data
Affiliations
History
  • Received:2024-06-28
  • Revised:2024-11-12
Affiliations
    Department of Hematology, Suzhou Municipal Hospital of Anhui Province, Suzhou 234000, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.02.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT